Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem IV Bolus vs Standard Infusion in Healthy Volunteers
NCT01148771Phase 4Completed
- Sponsor
- Hartford Hospital
- Start
- Aug 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ertapenem in bacterial infection (2 arms), sponsored by Hartford Hospital. Primary endpoints: Maximum Observed Plasma Concentration at Steady-State at Day 3 and Area Under the Curve From 48 to 72 Hours. Started Aug 2010; status: completed.
02
Drugs
ertapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT01148771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148771.